MARKSANS PHARMA. share price has zoomed 7% and is presently trading at Rs 175.4.
Meanwhile, the BSE HEALTHCARE index is at 38,055.6 (up 0.5%).
Among the top gainers in the BSE HEALTHCARE index today are Glenmark Pharma (up 2.5%) and FORTIS HEALTHCARE (up 2.3%).
ASTRAZENECA PHARMA (down 1.8%) and METROPOLIS HEALTHCARE (down 1.8%) are among the top losers today.
Over the last one year, MARKSANS PHARMA. has moved up from Rs 92.7 to Rs 175.4, registering a gain of Rs 82.7 (up 89.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 38,055.6, registering a gain of 48.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.3%), Cadila Healthcare (up 98.6%) and Lupin (up 97.8%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,532.1 (down 0.6%).
The top losers among the BSE Sensex today are HDFC Bank (down 4.1%) and M&M (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.
In the meantime, NSE Nifty is at 24,187.4 (down 0.5%). HDFC Bank and M&M are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,532.1, registering a gain of 14,327.1 points (up 22.0%).
MARKSANS PHARMA. net profit fell 6.1% YoY to Rs 776 million for the quarter ended March 2024, compared to a profit of Rs 827 million a year ago. Net sales rose 15.2% to Rs 5,600 million during the period as against Rs 4,860 million in January-March 2023.
For the year ended March 2023, MARKSANS PHARMA. reported 42.0% increase in net profit to Rs 2,653 million compared to net profit of Rs 1,868 million during FY22. Revenue of the company grew 24.2% to Rs 18,521 million during FY23.
The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 25.2.
Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 7%; BSE HEALTHCARE Index Up 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!